The role of biomarkers is increasingly recognized in heart failure (HF) management, for diagnosis, prognostication, and screening of high-risk patients. Beyond natriuretic peptides and troponins, the utility of novel, emerging biomarkers is less established. This document reflects the key points of a Heart Failure Association of the European Society of Cardiology (ESC) consensus meeting on biomarker monitoring in HF.

Spoletini, I., Coats, A., Senni, M., Rosano, G. (2019). Monitoring of biomarkers in heart failure. EUROPEAN HEART JOURNAL SUPPLEMENTS, 21, 5-8 [10.1093/eurheartj/suz215].

Monitoring of biomarkers in heart failure

Senni M;
2019

Abstract

The role of biomarkers is increasingly recognized in heart failure (HF) management, for diagnosis, prognostication, and screening of high-risk patients. Beyond natriuretic peptides and troponins, the utility of novel, emerging biomarkers is less established. This document reflects the key points of a Heart Failure Association of the European Society of Cardiology (ESC) consensus meeting on biomarker monitoring in HF.
Articolo in rivista - Articolo scientifico
Biomarkers; Heart failure; Monitoring;
English
5
8
4
Spoletini, I., Coats, A., Senni, M., Rosano, G. (2019). Monitoring of biomarkers in heart failure. EUROPEAN HEART JOURNAL SUPPLEMENTS, 21, 5-8 [10.1093/eurheartj/suz215].
Spoletini, I; Coats, A; Senni, M; Rosano, G
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/372720
Citazioni
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 14
Social impact